scholarly article | Q13442814 |
P2093 | author name string | Lee SD | |
Chao Y | |||
Huang TS | |||
Chiu JH | |||
Lui WY | |||
Shih YL | |||
Yang WK | |||
Chau GY | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | 985-990 | |
P577 | publication date | 1998-03-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma | |
P478 | volume | 58 |
Q35747423 | A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. |
Q53363710 | Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways. |
Q65002231 | As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma. |
Q64899142 | Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma. |
Q33608768 | Cell cycle control, checkpoint mechanisms, and genotoxic stress |
Q37693690 | Cell cycle proteins as promising targets in cancer therapy |
Q36612365 | Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma |
Q51513243 | Cyclin A and cyclin B1 overexpression in differentiated thyroid carcinoma. |
Q28361370 | Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription |
Q37293935 | Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin |
Q37484830 | Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas |
Q36066030 | Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer. |
Q38714300 | Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma |
Q33494037 | Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin |
Q33916747 | Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis |
Q35078603 | Male-specific hepatitis B virus large surface protein variant W4P potentiates tumorigenicity and induces gender disparity |
Q34458054 | Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections |
Q33222458 | Novel rapid tissue lysis method to evaluate cancer proteins: correlation between elevated Bcl-X(L) expression and colorectal cancer cell proliferation. |
Q24554609 | Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2 |
Q26827580 | Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors |
Q38178032 | The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations. |
Q24800464 | The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells |
Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Q38786439 | Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress |
Q58716568 | Zingerone Suppresses Tumor Development through Decreasing Cyclin D1 Expression and Inducing Mitotic Arrest |
Search more.